Objectives/Hypothesis To identify whether relationships exist between epistaxis and
migraines in hereditary hemorrhagic telangiectasia (HHT), to potentially provide further …

Objectives/Hypothesis To identify factors influencing the severity of epistaxis in hereditary
hemorrhagic telangiectasia (HHT). Study Design Participants with and without HHT were …

Objective A prospective, qualitative study was conducted to develop a patient‐reported
outcome measure (PROM) for daily administration via electronic diary (eDiary) to assess the …

Objectives/Hypothesis To examine whether there is a rationale for iron treatments
precipitating nosebleeds (epistaxis) in a subgroup of patients with hereditary hemorrhagic …

Abstract Objectives/Hypothesis: Hereditary hemorrhagic telangiectasia (HHT)‐related
epistaxis leads to alterations in social functioning and quality of life. Although more than …

Objectives/Hypothesis Hereditary hemorrhagic telangiectasia (HHT) is an autosomal
dominant vascular dysplasia whose hallmark symptom is spontaneous recurrent epistaxis …

Background: Epistaxis is the most common manifestation of hereditary hemorrhagic
telangiectasia (HHT), affecting approximately 90% of patients at some point during their …

Objectives The aim of this study (PROSPERO ID: CRD42017081952) was to evaluate
medical treatment for epistaxis from hereditary hemorrhagic telangiectasia (HHT). Data …

Background: There are currently no guidelines in the UK for the specific management of
hereditary haemorrhagic telangiectasia related epistaxis. The authors aimed to review the …

Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant
hereditary disorder resulting in vascular dysplasia and formation of arteriovenous …